BRANCACCIO JOHN P 4

What Happened
John P. Brancaccio, a director of OKYO Pharma Ltd (OKYO), was granted derivative rights covering 6,500 shares with an $1.85 price per share (total reported value $12,025) on 2026-06-08. The filing classifies this as an award/acquisition of a derivative security rather than an open-market purchase.

Key Details

• Transaction date: 2026-06-08; Form 4 filed: 2026-06-10 (timely filing).
• Award: 6,500 derivative shares at $1.85 per share; reported value $12,025.
• Vesting: 25% vests per year over four years, beginning on the first anniversary of the grant date.
• Shares owned after transaction: not specified in the available filing.
• Transaction code: A (award/grant); transaction treated as a derivative grant (not an immediate cash purchase). No 10b5-1 plan, tax withholding, or late-filing flags noted in the filing.

Context
This was a grant of derivative securities (typically stock options or similar) that give the right to acquire shares in the future subject to vesting — no immediate sale or open-market purchase occurred. Such awards are common for directors as compensation and do not by themselves indicate buying or selling sentiment until exercised or sold.